DUBLIN--(BUSINESS WIRE)--The "CAR T-cell Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for CAR T-cell Therapy was estimated ...

Avantor (AVTR) announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to immune cell therapy manufacturing and ...

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in viral vector manufacturing, today ...

Ipsen has secured exclusive global rights to BMX-502, a promising preclinical T-cell engager developed by Biomunex, aiming to harness MAIT cells for cancer treatment. This innovative bispecific ...

Managed by Rula Health. Your call or email may go to a representative. I am Dr. Neal McMann, and I am a licensed professional counselor in Arizona. I am a solution-focused strategic therapist who ...

Immunotech Biopharm Ltd has announced that foreign ownership restrictions on its partner Yongtai Ruike have been relaxed, allowing Beijing Yongtai to acquire full equity interest in the gene therapy ...

BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A ...

Barrington analyst Michael Petusky maintained a Buy rating on US Physical Therapy (USPH – Research Report) today and set a price target of $108.00. Michael Petusky has given his Buy rating due to a ...

Rocket Pharmaceuticals' strategic realignment initiative in July pulled funding from fanca-cel, which the biotech was ...